Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jun 19;12(6):3660-8.
doi: 10.3390/md12063660.

Siphonaxanthin, a green algal carotenoid, as a novel functional compound

Affiliations
Review

Siphonaxanthin, a green algal carotenoid, as a novel functional compound

Tatsuya Sugawara et al. Mar Drugs. .

Abstract

Siphonaxanthin is a specific keto-carotenoid in green algae whose bio-functional properties are yet to be identified. This review focuses on siphonaxanthin as a bioactive compound and outlines the evidence associated with functionality. Siphonaxanthin has been reported to potently inhibit the viability of human leukemia HL-60 cells via induction of apoptosis. In comparison with fucoxanthin, siphonaxanthin markedly reduced cell viability as early as 6 h after treatment. The cellular uptake of siphonaxanthin was 2-fold higher than fucoxanthin. It has been proposed that siphonaxanthin possesses significant anti-angiogenic activity in studies using human umbilical vein endothelial cells and rat aortic ring. The results of these studies suggested that the anti-angiogenic effect of siphonaxanthin is due to the down-regulation of signal transduction by fibroblast growth factor receptor-1 in vascular endothelial cells. Siphonaxanthin also exhibited inhibitory effects on antigen-induced degranulation of mast cells. These findings open up new avenues for future research on siphonaxanthin as a bioactive compound, and additional investigation, especially in vivo studies, are required to validate these findings. In addition, further studies are needed to determine its bioavailability and metabolic fate.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Structures of fucoxanthin (A); siphonaxanthin (B) and siphonein (C).

References

    1. Mabeau S., Fleurence J. Seaweed in food products: Biochemical and nutritional aspects. Trends Food Sci. Technol. 1993;4:103–107. doi: 10.1016/0924-2244(93)90091-N. - DOI
    1. Fleurence J. Seaweed proteins: Biochemical, nutritional aspects and potential uses. Trends Food Sci. Technol. 1999;10:25–28. doi: 10.1016/S0924-2244(99)00015-1. - DOI
    1. Peng J., Yuan J.P., Wu C.F., Wang J.H. Fucoxanthin, a marine carotenoid present in brown seaweeds and diatoms: Metabolism and bioactivities relevant to human health. Mar. Drugs. 2011;9:1806–1828. doi: 10.3390/md9101806. - DOI - PMC - PubMed
    1. Kumar S.R., Hosokawa H., Miyashita K. Fucoxanthin: A marine carotenoid exerting anti-cancer effects by affecting multiple mechanisms. Mar. Drugs. 2013;11:5130–5147. doi: 10.3390/md11125130. - DOI - PMC - PubMed
    1. Takaichi S. Carotenoids in algae: Distributions, biosynthesis and functions. Mar. Drugs. 2011;9:1101–1118. doi: 10.3390/md9061101. - DOI - PMC - PubMed

MeSH terms